New pentavalent vaccine launches in Indonesia
The one shot vaccine will be included in a new immunization program and will be available for infants from the ages of two months to one year. The pentavalent vaccine includes protection from Diphtheria, Tetanus, Pertussis, Hepatitis B and Haemophilus influenzae Type B.
"The use of pentavalent vaccine is expected to diminish production costs, cold chain costs, injector costs, and encourage health officers to be efficient," Juliman, the production director of Bio Farma, said "This cost efficiency will translate to affordability for the people."
The pentavalent vaccine has been in development from Bio Farma since 2007. The vaccine has passed all clinical trials and has been ensured to be safe for humans.
"This year we will produce and supply the vaccine to four provinces, West Java, Bali, NTB and Yogyakarta, while later we will be able to produce and fulfill the demand of all provinces of Indonesia," Juliman said.
Bio Farma was established in 1890 and since then has produced and supplied high quality vaccines. Bio Farma is currently one of the largest producers of vaccines in the world.